𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neuromuscular effects of sevoflurane in a patient with Myasthenia Gravis

✍ Scribed by Mayumi Nishi; Hiromi Nakagawa; Ruriko Komatsu; Takashi Natsuyama; Yoshifumi Tanaka

Publisher
Springer
Year
1993
Tongue
English
Weight
349 KB
Volume
7
Category
Article
ISSN
0913-8668

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cholinergic neuromuscular hyperactivity
Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody
✍ Anna Rostedt Punga; Roland Flink; HΓ₯kan Askmark; Erik V. StΓ₯lberg πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 151 KB

## Abstract A 75‐year‐old man with severe oculobulbar myasthenia gravis (MG) treated with acetylcholine esterase inhibitors (AChEIs) was found to have muscle‐specific tyrosine kinase (MuSK) antibodies. Neurophysiological examination displayed extra repetitive discharges after the compound motor act

Ocular myasthenia gravis in a patient wi
Ocular myasthenia gravis in a patient with euthyroid Graves' disease
✍ Terri P. Rose πŸ“‚ Article πŸ“… 1995 πŸ› Elsevier Science 🌐 English βš– 894 KB

Graves' disease (GD) and ocular myasthenia gravis (OMG) are autoimmune disorders which may occur in the same patient. Myasthenia gravis is 50 times more common in patients with Graves' disease when compared to the normal population. Typically, a patient may be diagnosed with one disorder and have no